Rabindra Kumar Jena MD PhD FICH FRCP (London) VTP (USA) BMT Physician
Professor and Head, Department of Clinical Haematology, SCB Medical College and Hospital, Cuttack, Odisha, India
"Sobre este título" puede pertenecer a otra edición de este libro.
Librería: Vedams eBooks (P) Ltd, New Delhi, India
Soft cover. Condición: New. Sickle cell disease (SCD) is an important public health problem, and India is the second most affected nation in the world. SCD has an immense impact in terms of premature mortality and low quality of life among SCD patients. Advances in the diagnosis, treatment and prevention of SCD have had a huge impact on the incidence and patients' health. However, timely development and implementation of cost-effective management strategies are vital to India. Much-needed guidelines for the management of SCD have been developed by the Indian College of Hematology (ICH) of the Indian Society of Hematology & Blood Transfusion (ISHBT) in collaboration with ICMR. These guidelines will be helpful for the doctors and researchers engaged in SCD care and indirectly for alleviating SCD patients' suffering. Nº de ref. del artículo: 160242
Cantidad disponible: 5 disponibles